CSCC´s ASC Heart failure study completed

Heart failure is a serious condition with a high morbidity and mortality. The patient enrolment and 1 year follow-up was finalized for all heart failure patients January 2021 in the Danish Ischemic Heart Failure phase II Trial (81 patients), in the International...

Cell2Cure in a Lung Transplantation study

Lung transplantation is the ultimate treatment of patients with severe lung disease. However, the short- and long-term prognosis is still problematic due to immunological reactions towards the transplanted lung. The first patient was successfully included January 2021...

Cell2Cure partner in a new Stem Cell Center

Cell2Cure, as part of the consortium Clinical Stem cell Innovation and production Center, CSIC, receives funding from Innovation Fund Denmark. CSIC embraces late-stage development of ASCs – it aims to mature process knowledge and product quality as a...